Synergistic drug combinations in AIDS therapy. Dipyridamole/3'-azido-3'-deoxythymidine in particular and principles of analysis in general
Combination chemotherapy has been prominent for more than a generation in the treatment of such diseases as cancer, hypertension, and bacterial infections. In the case of viral infections, combinations are coming rapidly into focus for the human immunodeficiency virus (HIV). Reasons for combination...
Gespeichert in:
| Veröffentlicht in: | Annals of the New York Academy of Sciences 1990, Vol.616 (1), p.367-384 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 384 |
|---|---|
| container_issue | 1 |
| container_start_page | 367 |
| container_title | Annals of the New York Academy of Sciences |
| container_volume | 616 |
| creator | Weinstein, J N Bunow, B Weislow, O S Schinazi, R F Wahl, S M Wahl, L M Szebeni, J |
| description | Combination chemotherapy has been prominent for more than a generation in the treatment of such diseases as cancer, hypertension, and bacterial infections. In the case of viral infections, combinations are coming rapidly into focus for the human immunodeficiency virus (HIV). Reasons for combination chemotherapy of HIV include synergy of antiviral effects, antagonism of toxicities, distribution of toxicities among organ systems, prevention of emergence of resistant variants, enhancement of immune function, and treatment of concurrent opportunistic infections. In the present paper two stories will be intertwined: a brief summary of our studies on combinations of the drug dipyridamole (DPM) with 3'-azido-3'-deoxythymidine (zidovudine, AZT) and other 2',3'-dideoxynucleosides; and presentation of a new approach to the analysis of drug combinations, as embodied in a computer program package called COMBO. |
| doi_str_mv | 10.1111/j.1749-6632.1990.tb17857.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_16110998</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16110998</sourcerecordid><originalsourceid>FETCH-LOGICAL-c288t-5397f64cd1b2c904efc88d61aefac38c2b50603c722f5d0a92df0f2e79da74883</originalsourceid><addsrcrecordid>eNo9UclOwzAQtRAIyvIJSBYHOCXYThrb3KqWTULiAJwtx0txlcTBTqSGT-CrSWjFXGY0M2-W9wC4wijFo91uUkxznhRFRlLMOUq7ElM2p-n2AMz-S4dghhClCeMkOwGnMW4QwoTl9BgcE0QZInwGft6GxoS1i51TUId-DZWvS9fIzvkmQtfAxfPqDXafJsh2SOHKtUNwWta-MrfZTSK_nfbJGGjjt0P3OdROu8ZMwFaGcWhfyQBlo2EbXKNcW5kIvR0zshqi-9uwNuMJsjoHR1ZW0Vzs_Rn4eLh_Xz4lL6-Pz8vFS6IIY10yzzi1Ra40LoniKDdWMaYLLI2VKmOKlHNUoExRQuxcI8mJtsgSQ7mWNGcsOwPXu7lt8F-9iZ2oXVSmqmRjfB8FLjBGnE-Nd7tGFXyMwVgx_lDLMAiMxCSE2IiJbTGxLSYhxF4IsR3Bl_stfVkb_Q_dM5_9Am76iIg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16110998</pqid></control><display><type>article</type><title>Synergistic drug combinations in AIDS therapy. Dipyridamole/3'-azido-3'-deoxythymidine in particular and principles of analysis in general</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Weinstein, J N ; Bunow, B ; Weislow, O S ; Schinazi, R F ; Wahl, S M ; Wahl, L M ; Szebeni, J</creator><contributor>McGowan, JJ (eds) ; St. Georgiev, V</contributor><creatorcontrib>Weinstein, J N ; Bunow, B ; Weislow, O S ; Schinazi, R F ; Wahl, S M ; Wahl, L M ; Szebeni, J ; McGowan, JJ (eds) ; St. Georgiev, V</creatorcontrib><description>Combination chemotherapy has been prominent for more than a generation in the treatment of such diseases as cancer, hypertension, and bacterial infections. In the case of viral infections, combinations are coming rapidly into focus for the human immunodeficiency virus (HIV). Reasons for combination chemotherapy of HIV include synergy of antiviral effects, antagonism of toxicities, distribution of toxicities among organ systems, prevention of emergence of resistant variants, enhancement of immune function, and treatment of concurrent opportunistic infections. In the present paper two stories will be intertwined: a brief summary of our studies on combinations of the drug dipyridamole (DPM) with 3'-azido-3'-deoxythymidine (zidovudine, AZT) and other 2',3'-dideoxynucleosides; and presentation of a new approach to the analysis of drug combinations, as embodied in a computer program package called COMBO.</description><identifier>ISSN: 0077-8923</identifier><identifier>EISSN: 1749-6632</identifier><identifier>DOI: 10.1111/j.1749-6632.1990.tb17857.x</identifier><identifier>PMID: 2078029</identifier><language>eng</language><publisher>United States</publisher><subject>Acquired Immunodeficiency Syndrome - drug therapy ; Dideoxynucleosides - therapeutic use ; Dipyridamole - therapeutic use ; Drug Synergism ; Drug Therapy, Combination ; Electronic Data Processing ; Zidovudine - therapeutic use</subject><ispartof>Annals of the New York Academy of Sciences, 1990, Vol.616 (1), p.367-384</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c288t-5397f64cd1b2c904efc88d61aefac38c2b50603c722f5d0a92df0f2e79da74883</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,778,782,787,788,4012,4038,4039,23917,23918,25127,27910,27911,27912</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2078029$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>McGowan, JJ (eds)</contributor><contributor>St. Georgiev, V</contributor><creatorcontrib>Weinstein, J N</creatorcontrib><creatorcontrib>Bunow, B</creatorcontrib><creatorcontrib>Weislow, O S</creatorcontrib><creatorcontrib>Schinazi, R F</creatorcontrib><creatorcontrib>Wahl, S M</creatorcontrib><creatorcontrib>Wahl, L M</creatorcontrib><creatorcontrib>Szebeni, J</creatorcontrib><title>Synergistic drug combinations in AIDS therapy. Dipyridamole/3'-azido-3'-deoxythymidine in particular and principles of analysis in general</title><title>Annals of the New York Academy of Sciences</title><addtitle>Ann N Y Acad Sci</addtitle><description>Combination chemotherapy has been prominent for more than a generation in the treatment of such diseases as cancer, hypertension, and bacterial infections. In the case of viral infections, combinations are coming rapidly into focus for the human immunodeficiency virus (HIV). Reasons for combination chemotherapy of HIV include synergy of antiviral effects, antagonism of toxicities, distribution of toxicities among organ systems, prevention of emergence of resistant variants, enhancement of immune function, and treatment of concurrent opportunistic infections. In the present paper two stories will be intertwined: a brief summary of our studies on combinations of the drug dipyridamole (DPM) with 3'-azido-3'-deoxythymidine (zidovudine, AZT) and other 2',3'-dideoxynucleosides; and presentation of a new approach to the analysis of drug combinations, as embodied in a computer program package called COMBO.</description><subject>Acquired Immunodeficiency Syndrome - drug therapy</subject><subject>Dideoxynucleosides - therapeutic use</subject><subject>Dipyridamole - therapeutic use</subject><subject>Drug Synergism</subject><subject>Drug Therapy, Combination</subject><subject>Electronic Data Processing</subject><subject>Zidovudine - therapeutic use</subject><issn>0077-8923</issn><issn>1749-6632</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1990</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9UclOwzAQtRAIyvIJSBYHOCXYThrb3KqWTULiAJwtx0txlcTBTqSGT-CrSWjFXGY0M2-W9wC4wijFo91uUkxznhRFRlLMOUq7ElM2p-n2AMz-S4dghhClCeMkOwGnMW4QwoTl9BgcE0QZInwGft6GxoS1i51TUId-DZWvS9fIzvkmQtfAxfPqDXafJsh2SOHKtUNwWta-MrfZTSK_nfbJGGjjt0P3OdROu8ZMwFaGcWhfyQBlo2EbXKNcW5kIvR0zshqi-9uwNuMJsjoHR1ZW0Vzs_Rn4eLh_Xz4lL6-Pz8vFS6IIY10yzzi1Ra40LoniKDdWMaYLLI2VKmOKlHNUoExRQuxcI8mJtsgSQ7mWNGcsOwPXu7lt8F-9iZ2oXVSmqmRjfB8FLjBGnE-Nd7tGFXyMwVgx_lDLMAiMxCSE2IiJbTGxLSYhxF4IsR3Bl_stfVkb_Q_dM5_9Am76iIg</recordid><startdate>1990</startdate><enddate>1990</enddate><creator>Weinstein, J N</creator><creator>Bunow, B</creator><creator>Weislow, O S</creator><creator>Schinazi, R F</creator><creator>Wahl, S M</creator><creator>Wahl, L M</creator><creator>Szebeni, J</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>1990</creationdate><title>Synergistic drug combinations in AIDS therapy. Dipyridamole/3'-azido-3'-deoxythymidine in particular and principles of analysis in general</title><author>Weinstein, J N ; Bunow, B ; Weislow, O S ; Schinazi, R F ; Wahl, S M ; Wahl, L M ; Szebeni, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c288t-5397f64cd1b2c904efc88d61aefac38c2b50603c722f5d0a92df0f2e79da74883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1990</creationdate><topic>Acquired Immunodeficiency Syndrome - drug therapy</topic><topic>Dideoxynucleosides - therapeutic use</topic><topic>Dipyridamole - therapeutic use</topic><topic>Drug Synergism</topic><topic>Drug Therapy, Combination</topic><topic>Electronic Data Processing</topic><topic>Zidovudine - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Weinstein, J N</creatorcontrib><creatorcontrib>Bunow, B</creatorcontrib><creatorcontrib>Weislow, O S</creatorcontrib><creatorcontrib>Schinazi, R F</creatorcontrib><creatorcontrib>Wahl, S M</creatorcontrib><creatorcontrib>Wahl, L M</creatorcontrib><creatorcontrib>Szebeni, J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Annals of the New York Academy of Sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Weinstein, J N</au><au>Bunow, B</au><au>Weislow, O S</au><au>Schinazi, R F</au><au>Wahl, S M</au><au>Wahl, L M</au><au>Szebeni, J</au><au>McGowan, JJ (eds)</au><au>St. Georgiev, V</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synergistic drug combinations in AIDS therapy. Dipyridamole/3'-azido-3'-deoxythymidine in particular and principles of analysis in general</atitle><jtitle>Annals of the New York Academy of Sciences</jtitle><addtitle>Ann N Y Acad Sci</addtitle><date>1990</date><risdate>1990</risdate><volume>616</volume><issue>1</issue><spage>367</spage><epage>384</epage><pages>367-384</pages><issn>0077-8923</issn><eissn>1749-6632</eissn><abstract>Combination chemotherapy has been prominent for more than a generation in the treatment of such diseases as cancer, hypertension, and bacterial infections. In the case of viral infections, combinations are coming rapidly into focus for the human immunodeficiency virus (HIV). Reasons for combination chemotherapy of HIV include synergy of antiviral effects, antagonism of toxicities, distribution of toxicities among organ systems, prevention of emergence of resistant variants, enhancement of immune function, and treatment of concurrent opportunistic infections. In the present paper two stories will be intertwined: a brief summary of our studies on combinations of the drug dipyridamole (DPM) with 3'-azido-3'-deoxythymidine (zidovudine, AZT) and other 2',3'-dideoxynucleosides; and presentation of a new approach to the analysis of drug combinations, as embodied in a computer program package called COMBO.</abstract><cop>United States</cop><pmid>2078029</pmid><doi>10.1111/j.1749-6632.1990.tb17857.x</doi><tpages>18</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0077-8923 |
| ispartof | Annals of the New York Academy of Sciences, 1990, Vol.616 (1), p.367-384 |
| issn | 0077-8923 1749-6632 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_16110998 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Acquired Immunodeficiency Syndrome - drug therapy Dideoxynucleosides - therapeutic use Dipyridamole - therapeutic use Drug Synergism Drug Therapy, Combination Electronic Data Processing Zidovudine - therapeutic use |
| title | Synergistic drug combinations in AIDS therapy. Dipyridamole/3'-azido-3'-deoxythymidine in particular and principles of analysis in general |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T19%3A29%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synergistic%20drug%20combinations%20in%20AIDS%20therapy.%20Dipyridamole/3'-azido-3'-deoxythymidine%20in%20particular%20and%20principles%20of%20analysis%20in%20general&rft.jtitle=Annals%20of%20the%20New%20York%20Academy%20of%20Sciences&rft.au=Weinstein,%20J%20N&rft.date=1990&rft.volume=616&rft.issue=1&rft.spage=367&rft.epage=384&rft.pages=367-384&rft.issn=0077-8923&rft.eissn=1749-6632&rft_id=info:doi/10.1111/j.1749-6632.1990.tb17857.x&rft_dat=%3Cproquest_cross%3E16110998%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16110998&rft_id=info:pmid/2078029&rfr_iscdi=true |